At birth, two types of cells can be collected, the first is umbilical cord blood. This is the blood which remains in the umbilical cord and placenta following birth. The blood contains a vast number of potentially life-saving stem cells and can be easily collected after the birth of your child. Cord blood can be processed, and stem cells stored for later use in the treatment of many diseases and disorders. Today, over 80 diseases have been treated using umbilical cord blood stem cells.
The second is the umbilical cord itself, often referred to as cord tissue. Umbilical cord tissue has been shown to contain stem cells which have the potential to repair bone, cartilage, nerves and connective tissue in regenerative medicine technology.
Widecells Group PLC (LON:WDC) are leading a transformation in cord blood banking and stem cell treatment; making cord blood banking more accessible through insurance coverage, and increasing the availability of cord blood for transplants.